Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | DIRK VAN DE PUTDirector, Chief Executive Officer |  MDLZMondelez International, Inc.Option exercise · 10b5-1 plan | M | — 108.4K sh |
| Nov 6, 2026 traded Nov 4, 2026 |
| 0 | DIRK VAN DE PUTDirector, Chief Executive Officer | MDLZMondelez International, Inc. Option exercise · 10b5-1 plan | M | — 20.9K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Zerbe Robert L MdDirector |  VCELVericel CorpOption exercise · 10b5-1 plan | M | $33K 2,500 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Zerbe Robert L MdDirector | VCELVericel Corp Option exercise · 10b5-1 plan | M | — 500 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Zerbe Robert L MdDirector | VCELVericel Corp Option exercise · 10b5-1 plan | M | — 2,500 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks |  YOUClear Secure, Inc.Option exercise · 10b5-1 plan | M | — 176.1K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 176.1K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 176.1K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Michaelson JenniferChief Scientific Officer |  CGEMCullinan Therapeutics, Inc.Option exercise · 10b5-1 plan | M | $16K 3,805 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Siegal JonathanPrincipal Accounting Officer | VCELVericel Corp Option exercise · 10b5-1 plan | M | — 1,500 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | King Ryan ADirector, Co-Founder |  CHYMChime Financial, Inc.Derivative conversion · 10b5-1 plan | C | — 63.4K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Skates SpenserDirector, CEO and President, 10% Owner |  AMPLAmplitude, Inc.Derivative conversion · 10b5-1 plan | C | — 61 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Option exercise · 10b5-1 plan | M | $75K 12.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 176.1K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 176.1K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Seidman Becker CarynDirector, Chief Executive Officer, 10% Owner | YOUClear Secure, Inc. Option exercise · 10b5-1 plan | M | — 176.1K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Skates SpenserDirector, CEO and President, 10% Owner | AMPLAmplitude, Inc. Derivative conversion · 10b5-1 plan | C | — 901 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Azar Samak LChief Legal Officer |  GFSGLOBALFOUNDRIES Inc.Open-market sale · 10b5-1 plan | SELL | $13K 335 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $14K 500 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Fairbank Richard DDirector, Chairman and CEO |  COFCAPITAL ONE FINANCIAL CORPOption exercise · 10b5-1 plan | M | — 40.7K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Peters William JDirector, CFO, EVP & TREASURER |  AMPHAmphastar Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | — 16.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Peters William JDirector, CFO, EVP & TREASURER | AMPHAmphastar Pharmaceuticals, Inc. Option exercise · 10b5-1 plan | M | — 11.0K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Patel Sanj KDirector, CHAIRMAN & CEO |  KNSAKiniksa Pharmaceuticals International, plcOption exercise · 10b5-1 plan | M | — 145.8K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $144K 11.9K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 0 | Skates SpenserDirector, CEO and President, 10% Owner | AMPLAmplitude, Inc. Derivative conversion · 10b5-1 plan | C | — 901 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Skates SpenserDirector, CEO and President, 10% Owner | AMPLAmplitude, Inc. Derivative conversion · 10b5-1 plan | C | — 61 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Duffy Sean P.Director, Chief Executive Officer | OMDAOmada Health, Inc. Option exercise · 10b5-1 plan | M | — 12.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.9K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Option exercise · 10b5-1 plan | M | — 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Option exercise · 10b5-1 plan | M | — 900 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 57 | Liu ShaorenDirector, CEO and CFO, 10% Owner |  TRADAPEX Tech Acquisition Inc.Open-market purchase | BUY | $2.09M 209.0K sh | Nov 5, 2026 traded Feb 27, 2026 |
| 57 | Zoghbi Huda YDirector |  REGNREGENERON PHARMACEUTICALS, INC.Open-market sale | SELL | $6.73M 6,939 sh | Nov 5, 2026 traded Nov 3, 2026 |
| 56 | Liu ShaorenDirector, CEO and CFO, 10% Owner | TRADAPEX Tech Acquisition Inc. Open-market purchase | BUY | — 209.0K sh | Nov 5, 2026 traded Feb 27, 2026 |
| 55 | Lee Kelvin Soon SzeDirector |  SPPLSIMPPLE LTD.Open-market sale | SELL | $51.25B 189.3K sh | Nov 5, 2026 traded Nov 4, 2026 |
| 55 | Pat Daryl Kah KitActing Chief Executive Officer | SPPLSIMPPLE LTD. Open-market sale | SELL | $10.20B 62.9K sh | Nov 5, 2026 traded Nov 4, 2026 |
| 55 | Soo QiKaiChief Technology Officer | SPPLSIMPPLE LTD. Open-market sale | SELL | $5.74B 47.2K sh | Nov 5, 2026 traded Nov 4, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K